#	Pagina
attuale pagina	/open-h2020/projects/221999/index.html
-1	/open-h2020/projects/226854/index.html

Opendata, web and dolomites

BispecificsThatClick SIGNED

Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators

Total Cost €

EC-Contrib. €

Partnership

Views

BispecificsThatClick project word cloud

Explore the words cloud of the BispecificsThatClick project. It provides you a very rough idea of what is the project "BispecificsThatClick" about.

anticancer condensation medicine platform efficiency mode cancer mabs tissues simultaneously binding responsible scientific of immune slow acceleration library speed monoclonal substrates therapeutic constructs immunondulatory herein serve healthy antigen action reactions cell inverse inefficiency cells linear site carcinogenic throughput modality bioorthogonal electron diels identification classic tagged antibodies antigens fight linkers combinations kill treatment lack modern imaging select ligation trigger treatments led bind malignant alder immunology specificities tested selectively tumour efficacy tools lot tedious assembled synthesis bispecific content bsabs scaffold lie methodology demand consist community combination significantly strategies extense anti tag harnessing

Project "BispecificsThatClick" data sheet

The following table provides information about the project.

Coordinator	THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE Organization address address: TRINITY LANE THE OLD SCHOOLS city: CAMBRIDGE postcode: CB2 1TN website: www.cam.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Total cost	212˙933 €
EC max contribution	212˙933 € (100%)
Programme	1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
Code Call	H2020-MSCA-IF-2018
Funding Scheme	MSCA-IF-EF-ST
Starting year	2019
Duration (year-month-day)	from 2019-06-03 to 2021-06-02

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE Organization address address: TRINITY LANE THE OLD SCHOOLS city: CAMBRIDGE postcode: CB2 1TN website: www.cam.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (CAMBRIDGE)	coordinator	212˙933.00

Map

Project objective

Cancer represents one of the major challenges for modern medicine as we still lack tools to selectively target malignant over healthy tissues. The main issues with state of the art anti-cancer treatments lie on their inefficiency and their associated side-effects. Improving this treatments has focused a lot of attention of the scientific community and has led to the development of new strategies. Harnessing our own immune system to fight malignant cells is one of the strategies with promising potential to improve cancer treatments, although challenges still remain. An emerging therapeutic modality to trigger our immune system against carcinogenic tissues are bispecific antibodies (bsAbs). bsAbs are the combination of two antigen binding specificities on a common scaffold. The potential of these constructs to bind to two antigens can be used to simultaneously target cancer cells and the immune cell which will effectively kill it. The problem of bsAbs is their slow and tedious production process, which is responsible for their linear development. Herein we propose a methodology to speed up and improve the efficiency of their production. Our approach will consist in using novel site-specific bioorthogonal ligation reactions to tag monoclonal antibodies (mAbs) with linkers that will serve as substrates for an inverse electron demand Diels Alder condensation. By condensation of different combinations of tagged mAbs a library of bsAbs will be assembled. The immunondulatory properties of the bsAbs will be tested in high throughput using a high content imaging platform. We will be able to select potential bsAbs for anticancer treatment from our extense library which will study in more depth using classic immunology methods to determine their mode of action and their anti tumour efficacy. The acceleration of both the synthesis and identification of relevant bsAbs for anticancer treatments would significantly increase the presence and value of this technology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BISPECIFICSTHATCLICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BISPECIFICSTHATCLICK" are provided by the European Opendata Portal: CORDIS opendata.